Neuroprotection for treatment of glaucoma in adults (Q24200657)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

The number of people with glaucoma worldwide in 2010 and 2020

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Global data on visual impairment in the year 2002

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Medical interventions for primary open angle glaucoma and ocular hypertension

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

How to identify randomized controlled trials in MEDLINE: ten years on

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Clinical trials for glaucoma neuroprotection are not impossible

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Basic and clinical studies of pressure-independent damaging factors of open angle glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Neuroprotection in glaucoma: recent and future directions

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Use of calcium channel blockers for glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Lack of association of polymorphisms in elastin with pseudoexfoliation syndrome and glaucoma.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Neuroprotection: extrapolating from neurologic diseases to the eye.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Neuroprotection in glaucoma: drug-based approaches.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Current management of glaucoma and the need for complete therapy.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

History of neuroprotection and rationale as a therapy for glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Evolving paradigms in the medical treatment of glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Gene-environment interactions in human diseases

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Early Manifest Glaucoma Trial update 2004

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Prevalence of open-angle glaucoma among adults in the United States

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Evaluation of neuroprotective qualities of brimonidine during LASIK.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Some Current Ideas on the Pathogenesis and the Role of Neuroprotection in Glaucomatous Optic Neuropathy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Medical treatment of normal tension glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Assessment of the retinal nerve fiber layer in clinical trials of glaucoma neuroprotection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Neuroprotection: a new treatment modality for glaucoma?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study Group

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Is neuroprotection a viable therapy for glaucoma?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

New definitions of glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Normal tension glaucoma--a practical approach

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Vertical cup/disc ratio in relation to optic disc size: its value in the assessment of the glaucoma suspect

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Neuronal death in glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Changing definition of glaucoma.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Clinical evidence for neuroprotection in glaucoma.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Natural history of normal-tension glaucoma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Retrobulbar Arterial Hemodynamic Effects of Betaxolol and Timolol in Normal-Tension Glaucoma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients

30 May 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Advances in glaucoma treatment and management: neurotrophic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Short-term effects of bimatoprost in glaucoma patients from an outpatient clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: a 3-month clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

A comparison of the fixed combination of latanoprost and timolol with its individual components

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Distribution of optineurin sequence variations in an ethnically diverse population of low-tension glaucoma patients from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Nitric oxide synthase in the human glaucomatous optic nerve head.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Accuracy of clinical estimates of intraocular pressure in Chinese eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB3

Glaucoma neuroprotection--how far is it from a dream to reality

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Special considerations in low-tension glaucoma

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Neuroprotection with carotenoids in glaucoma

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4261923

10.1002/14651858.CD006539.PUB3

29 November 2018

Identifiers

DOI

1 reference

1 reference

1 reference

PubMed publication ID

23450569

1 reference